SCHEMBL11267013

SCHEMBL11267013

CC(CCCl)Oc1ccccc1C=O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.49
HPGD P15428 1/20 0.49
HTT P42858 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
ADRA2A P08913 1/20 0.45
ADRA2B P18089 1/20 0.45
ADRA2C P18825 1/20 0.45
LMNA P02545 3/20 0.42
KMT2A Q03164 3/20 0.42
GAA P10253 1/20 0.42
PTGDR2 Q9Y5Y4 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
SRC P12931 2/20 0.40
MEN1 O00255 2/20 0.38
THRB P10828 1/20 0.38
BLM P54132 1/20 0.38
TDP1 Q9NUW8 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28935895 0.85 ALDH1A1 (0.50) ALDH1A1HPGDHTTSMN1; SMN2ADRA2A
SCHEMBL29165171 0.83 ALDH1A1 (0.47) ALDH1A1HPGDHTTSMN1; SMN2ADRA2A
SCHEMBL11673199 0.81 ALDH1A1 (0.53) ALDH1A1HPGDHTTSMN1; SMN2ADRA2A
SCHEMBL10746717 0.80 ALDH1A1 (0.52) ALDH1A1HPGDHTTSMN1; SMN2ADRA2A
SCHEMBL8940216 0.80 ALDH1A1 (0.52) ALDH1A1HPGDHTTSMN1; SMN2ADRA2A
SCHEMBL2820699 0.79 ALDH1A1 (0.55) ALDH1A1HPGDHTTSMN1; SMN2ADRA2A
SCHEMBL28061827 0.78 ALDH1A1 (0.52) ALDH1A1HPGDHTTSMN1; SMN2ADRA2A
SCHEMBL177279 0.77 ALDH1A1 (0.55) ALDH1A1HPGDHTTSMN1; SMN2ADRA2A
SCHEMBL11323988 0.75 ALDH1A1 (0.53) ALDH1A1HPGDHTTSMN1; SMN2ADRA2A
SCHEMBL7769241 0.74 ALDH1A1 (0.49) ALDH1A1HPGDHTTSMN1; SMN2ADRA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0050585-A1 1,5-Bis-(1,4-benzodioxin-2-yl)-3-azapentane-1,5 diols, process for their preparation, pharmaceutical preparations containing them and their therapeutical use CIBA-GEIGY AG (CH) 1982-04-28 EP disclosed